Novel Prognostic Markers in Renal Cancer
NCT01002937 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 182
Last updated 2024-06-18
Summary
The purpose of this project is to analyze tumour tissue from a group of subjects with renal cell carcinoma, who have been treated at the Royal Marsden Hospital.
Conditions
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Professor Martin Gore · Royal Marsden NHS Foundation Trust
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-01
- Primary Completion
- 2014-12-17
- Completion
- 2014-12-17
Countries
- United Kingdom
Study Locations
More Related Trials
-
Biomarker Analysis of Central Nervous System Tumors
NCT02692898 ·Status: TERMINATED
-
Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
NCT06868927 ·Status: RECRUITING
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Molecular Markers in Adrenal Tumors
NCT01348698 ·Status: TERMINATED
-
NANOTECH RCC Biomarkers
NCT02923284 ·Status: COMPLETED
-
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
NCT00899860 ·Status: TERMINATED
-
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
NCT03947346 ·Status: COMPLETED
-
RDC Biomarker Study
NCT05876676 ·Status: RECRUITING
-
Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
NCT00230308 ·Status: RECRUITING
-
Molecular Markers in Predicting Response to Treatment in FH-deficient RCC Patients
NCT05535829 ·Status: UNKNOWN
-
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence
NCT05410028 ·Status: RECRUITING
-
CIRcular and Non-coding RNAs as Clinically USeful Biomarkers in Pancreaticobiliary Cancers
NCT04584996 ·Status: UNKNOWN
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
NCT00568490 ·Status: RECRUITING
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Prognostic Markers for a Better Follow-up in Head and Neck Cancer.
NCT06094985 ·Status: RECRUITING
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
NCT02906943 ·Status: RECRUITING
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING ·Phase: NA
-
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
NCT01063998 ·Status: TERMINATED
-
Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
NCT00539318 ·Status: TERMINATED
-
Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.
NCT02036216 ·Status: UNKNOWN
-
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
NCT01642095 ·Status: WITHDRAWN
-
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
NCT01831609 ·Status: UNKNOWN